All these treatments are performed outside Spain, in Eastern European countries, within the European Union, and/or in Middle Eastern countries, where there is NO prohibition as in Spain for the application of these treatments.
We advise all cancer patients to read this IMPORTANT book about the reality of cancer. CANCER: THE SURPRISING TRUTH. Its author is the prestigious molecular biologist Travis Christofferson. We recommend it for all cancer patients and of course for all physicians and oncologists.
Specific active immunotherapy with Dendritic Cell Vaccines (DCV) is a newly emerging and potent form of cancer immunotherapy that has clinically relevant mechanisms of action with great potential for the systemic treatment of cancers. It aims to reprogram the anti-tumour immune response from cancer accepting (tolerogenic) to cancer destroying (immunogenic) state. DCV does not affect the cancer directly; the therapeutic effect is instead caused by “nurturing” the immune system so that rather than tolerating the cancer cells, it recognizes them and takes action to control their activities.
Dendritic cells are collected from patient’s blood, loaded with tumor antigens and matured in a specially designed GMP (Good Manufacturing Practice) laboratory which meets strict quality control and surveillance requirements. Once loaded with tumour antigens and matured correctly, dendritic cells are being activated to induce the immune response when injected back into patient’s bloodstream. It does not directly affect cancer and has a therapeutic effect by "nurturing" the immune system and forcing it to recognize and control cancer cells rather than tolerate them.
Request information without obligation, we will study your case with our medical team to give you an answer as soon as possible.